Thursday, Jan 27, 2022 | Last Update : 01:34 PM IST

cipla ltd

Pfizer tells Centre its vaccine suitable for 12 years and above

The drugmaker is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions

27 May 2021 12:19 PM

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

ADVERTISEMENT
ADVERTISEMENT